Literature DB >> 18519089

Vasopressin and aquaporin 2 in clinical disorders of water homeostasis.

Robert W Schrier1.   

Abstract

Impaired urinary dilution leading to water retention and hyponatremia may occur in patients with cardiac failure, cirrhosis, pregnancy, oxytocin administration, hypothyroidism, glucocorticoid, and mineralocorticoid deficiency. The mechanisms for these defects predominantly involve the nonosmotic stimulation of arginine vasopressin release with up-regulation of aquaporin 2 water channel expression and trafficking to the apical membrane of the principal cells of the collecting duct. These perturbations are reversed by V2 vasopressin receptor antagonists. In contrast, urinary concentration defects leading to polyuria are vasopressin resistant. They may involve several factors, such as impaired countercurrent concentration secondary to down-regulation of Na-K-2Cl cotransporter. Vasopressin-resistant down-regulation of aquaporin 2 expression has also been described as a factor in impaired urinary concentration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519089      PMCID: PMC2587374          DOI: 10.1016/j.semnephrol.2008.03.009

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  53 in total

1.  Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy.

Authors:  M A Cadnapaphornchai; M Ohara; K G Morris; M Knotek; B Rogachev; T Ladtkow; E P Carter; R W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2001-04

2.  Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.

Authors:  Alexander L Gerbes; Veit Gülberg; Pere Ginès; Guy Decaux; Peter Gross; Hassan Gandjini; Jacques Djian
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

Review 3.  Tubular reabsorption of sodium ion: influence of factors other than aldosterone and glomerular filtration rate. 1.

Authors:  R W Schrier; H E De Wardener
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

4.  Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management.

Authors:  Ewout J Hoorn; Jan Lindemans; Robert Zietse
Journal:  Nephrol Dial Transplant       Date:  2005-09-02       Impact factor: 5.992

5.  Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure.

Authors:  V L Szatalowicz; P E Arnold; C Chaimovitz; D Bichet; T Berl; R W Schrier
Journal:  N Engl J Med       Date:  1981-07-30       Impact factor: 91.245

6.  Urea transporter UT-A1 and aquaporin-2 proteins decrease in response to angiotensin II or norepinephrine-induced acute hypertension.

Authors:  Janet D Klein; Brian P Murrell; Suzanne Tucker; Young-Hee Kim; Jeff M Sands
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-20

Review 7.  The sea within us: disorders of body water homeostasis.

Authors:  Robert W Schrier
Journal:  Curr Opin Investig Drugs       Date:  2007-04

Review 8.  Decreased effective blood volume in edematous disorders: what does this mean?

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2007-06-13       Impact factor: 10.121

9.  Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion.

Authors:  W Wang; C Li; S N Summer; S Falk; R W Schrier
Journal:  Kidney Int       Date:  2007-08-15       Impact factor: 10.612

10.  Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat.

Authors:  S R DiGiovanni; S Nielsen; E I Christensen; M A Knepper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more
  23 in total

1.  Acute changes in systemic hemodynamics and serum vasopressin after complete cervical spinal cord injury in piglets.

Authors:  Michael Zahra; Amer Samdani; Kurt Piggott; Manuel Gonzalez-Brito; Juan Solano; Roosevelt De Los Santo; Juan C Buitrago; Farid Alam; Dansha He; John P Gaughan; Randal Betz; Dalton Dietrich; John Kuluz
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

Review 2.  Aquaporins in kidney pathophysiology.

Authors:  Yumi Noda; Eisei Sohara; Eriko Ohta; Sei Sasaki
Journal:  Nat Rev Nephrol       Date:  2010-01-26       Impact factor: 28.314

Review 3.  Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders.

Authors:  Yumi Noda
Journal:  Clin Exp Nephrol       Date:  2013-10-16       Impact factor: 2.801

Review 4.  Regulation of transport in the connecting tubule and cortical collecting duct.

Authors:  Alexander Staruschenko
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

Review 5.  Osmotic homeostasis.

Authors:  John Danziger; Mark L Zeidel
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-30       Impact factor: 8.237

6.  Comparison of renal predictors for in-hospital and postdischarge mortality after hospitalized heart failure.

Authors:  Gurjit Singh; Edward L Peterson; Karen Wells; L Keoki Williams; David E Lanfear
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2012-04       Impact factor: 2.160

Review 7.  Diuretic use in renal disease.

Authors:  Domenic A Sica
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

Review 8.  Diagnosis and management of hyponatremia in cancer patients.

Authors:  Jorge J Castillo; Marc Vincent; Eric Justice
Journal:  Oncologist       Date:  2012-05-22

9.  Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling.

Authors:  Elena A Zalyapin; Richard Bouley; Udo Hasler; Jean-Pierre Vilardaga; Herbert Y Lin; Dennis Brown; Dennis A Ausiello
Journal:  Kidney Int       Date:  2008-08-27       Impact factor: 10.612

Review 10.  [Disorders of water and sodium balance in intensive care patients].

Authors:  M Lichtwarck-Aschoff; B Dietrich; D Breitschaft
Journal:  Anaesthesist       Date:  2009-05       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.